Unbound MEDLINE

Molecular biology and targeted therapy of cutaneous T-cell lymphomas. Giornale italiano di dermatologia e venereologia : organo ufficiale, Società italiana di dermatologia e sifilografia [G Ital Dermatol Venereol] Journal article

 
TitleMolecular biology and targeted therapy of cutaneous T-cell lymphomas.
Author(s)Klemke CD, Goerdt S 
InstitutionDepartment of Dermatology, Venereology and Allergology, University Medical Center Mannheim, Ruprecht-Karls-University of Heidelberg, Mannheim, Germany claus-detlev.klemke@haut.ma.uni-heidelberg.de.
SourceG Ital Dermatol Venereol 2008 Dec; 143(6):365-74.
AbstractCutaneous T-cell lymphoma (CTCL) is an extra-nodal non-Hodgkin lymphoma of mature T cells. These tumor cells home to and persist in the skin, producing a broad spectrum of clinical entities. Recent results of basic research on tumor biology and tumor immunology as well as molecular genetics of cutaneous T-cell lymphoma have fostered the development of new therapeutic approaches. Several clinical trials testing these targeted therapies have shown encouraging results. This article provides an overview of recent research developments and therapeutic strategies for cutaneous T-cell lymphoma.
Languageeng
Pub Type(s)Journal Article
PubMed ID19169209
  
Advertise on this site.